IQV
IQVIA Holdings Inc

1,159
Mkt Cap
$36.42B
Volume
1.45M
52W High
$225.91
52W Low
$134.65
PE Ratio
29.36
IQV Fundamentals
Price
$210.96
Prev Close
$213.88
Open
$210.86
50D MA
$197.52
Beta
1.15
Avg. Volume
1.8M
EPS (Annual)
$7.49
P/B
5.91
Rev/Employee
$175,056.82
Loading...
Loading...
News
all
press releases
IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·7d ago
News Placeholder
More News
News Placeholder
IQVIA Earnings & Revenues Beat Estimates in Q3, Increase Y/Y
IQV posts stronger-than-expected third-quarter 2025 earnings and revenue gains. It lifts the full-year guidance as all key segments show growth momentum.
Zacks·7d ago
News Placeholder
IQVIA Holdings (IQV) Tops Q3 Earnings and Revenue Estimates
IQVIA (IQV) delivered earnings and revenue surprises of +1.35% and +0.86%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
News Placeholder
IQVIA Reports Third-Quarter 2025 Results
IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today...
Business Wire·8d ago
News Placeholder
IQVIA Gears Up to Report Q3 Earnings: What's in the Cards?
IQV readies its Q3 report, with revenues and EPS expected to rise on biopharma strength and cost control despite muted beat odds.
Zacks·12d ago
News Placeholder
TransMedics (TMDX) Reports Next Week: Wall Street Expects Earnings Growth
TransMedics (TMDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·13d ago
News Placeholder
IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025
IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries...
Business Wire·14d ago
News Placeholder
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·14d ago
News Placeholder
Is Veeva's Vault CRM Emerging as the Standard for Top Biopharma?
VEEV's Vault CRM is gaining traction with top biopharma firms like Merck, Gilead, and BMS, signaling its rise as the industry's commercial standard.
Zacks·1mo ago
News Placeholder
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·2mo ago

Latest IQV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.